Search results
Viatris Inc. (VTRS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic Shifts and ...
GuruFocus.com via Yahoo Finance· 5 days agoThrough strategic divestitures, focused operational growth, and robust financial management, Viatris...
US FTC Continues Aggressive Scrutiny of Pharmaceutical Patents Listed in the Orange Book | JD Supra
JD Supra· 6 days agoOn April 30, 2024, the US Federal Trade Commission (“FTC”) announced that it had sent “warning letters” to 10 branded pharmaceutical manufacturers, alleging that the companies ...
Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary...
JD Supra· 6 days ago...the Judicial Panel on Multidistrict Litigation recently granted Regeneron Pharmaceutical’s (“Regeneron”) motion to establish a multi-district litigation (“MDL”) for its aflibercept BPCIA litigation...N.D.W.V.”) and consolidated for pretrial proceedings with Regeneron’s actions pending there...
Viagra maker Viatris misses revenue estimates on weak demand for older drugs
Reuters via AOL· 7 days agoNet sales in its branded drugs unit, which makes up two-thirds of the company's total revenues, also fell 4.5% to $2.31 billion. Viatris, formed by the merger of Mylan and ...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A C
Guru Focus· 1 day agoWith a Loss Per Share of 0.06, the question arises: is Viatris modestly overvalued? This article delves into a detailed valuation analysis to help investors make informed decisions. Viatris ...
Earnings call: Viatris reports strong Q1 with revenue of $3.7 billion By Investing.com
Investing.com· 6 days agoViatris Inc. (NASDAQ: NASDAQ:VTRS) has reported robust financial results for the first quarter of...
Fancy Pharmacy Packs Will Pay Dividends
PlasticsToday.com· 7 days agoIt wowed pharmacy customers with its simplistic, yet informative, easy-to-read label and color-coded rings. Then Target sold its in-store pharmacies to...